Category Archives: Biotech

The ongoing search for the better early-stage clinical trial location: a case study on Australia and Georgia

International biotech and medtech companies are constantly searching for optimal locations for their early stage and proof-of-concept clinical trials. An example of a location that has become increasingly popular is Australia. This is in large part due to the great … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, FDA, Medical Devices, Patient Enrolment | Leave a comment

Clinical Accelerator collaborates with Thrombolytic Science International to study a tPA/mutant pro-urokinase dual regimen for thrombolysis in acute myocardial infarction

Clinical Accelerator, a full-service contract research organization, has entered into a collaboration with Thrombolytic Science International (TSI) to conduct a phase II randomised, multi-centre, open-label, parallel group mechanistic study using TSI’s dual treatment regimen in patients with ST elevation myocardial … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

Clinical Accelerator announces collaboration with Archivel Farma in a phase IIa Clinical Trial for RUTI®: a therapeutic vaccination against Multi-Drug Resistant Tuberculosis

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Archivel Farma, for conducting a phase IIa clinical trial for their therapeutic vaccine RUTI® against multi-drug Resistant tuberculosis. The double-blind, randomized … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

Temple Therapeutics BV Announces Publication of Key Mechanism Data for Evitar™

Below, we are re-publishing with permission the press-release issued by Temple Therapeutics BV on the 10th of September 2018 Supports Evitar’s™ Novel Approach for Preventing Acute Tissue Fibrosis (Surgical Adhesions) Geleen, The Netherlands Temple Therapeutics BV (the “Company” or “Temple”)- September … Continue reading

Posted in Biotech, Clinical Accelerator | Leave a comment

Clinical Accelerator announces collaboration with Oncolix for developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Oncolix, for conducting clinical studies for its analogue protein, Prolanta, to treat ovarian cancer. The trials will be conducted in the … Continue reading

Posted in Biotech, Central and Eastern Europe, Clinical Accelerator | Leave a comment